global-new-drug-delivery-systems-market-analysis-forecasts-2014-2020-industry
Published

August 2016

Global Novel Drug Delivery Systems(NDDS) Market - Analysis and Forecasts (2016 - 2021)

Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license

The global market for Novel Drug Delivery Systems (NDDS) is expected to hit USD 320 billion by the year 2021.

Unprecedented developments in genomics and molecular biology today offer a plethora of new drug targets. The method by which a drug is delivered to these targets can have a significant impact on its efficacy. Some drugs have an optimum concentration spectrum within which maximum benefit is derived, and concentrations out of this range can be toxic or produce no therapeutic benefit at all. This, with the very slow progress in the efficacy of the treatment of severe diseases, has suggested a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues. It is estimated that close to 50% of the newly developed drugs cannot be taken orally.

This increase in numbers for the NDDS market is to be driven by the increased requirement for improving the efficacy, safety and bio-recognition of drugs for disease-specific sites within the body, and also the need to improve the comfort levels of patient who are the users of the drugs.

These requirements have led to the need for controlling the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, bio-recognition, and efficacy of drugs, in turn leading to the birth of drug delivery systems. The introduction of novel delivery systems to an existing molecule should significantly improve its safety, efficacy, and patient compliance. Most of the innovator companies have a parallel research pipeline for biopharmaceuticals and concentrate also on innovative delivery platforms.

The market has been segmented by route of administration (oral, injectable, pulmonary, transdermal and others) and by geography (North America, Europe, Asia-Pacific and the Rest of the World).

Some of the key players in the market are:

  • Genentech Inc.
  • Generex Biotechnology Corporation
  • Genzyme Corporation
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Mannkind Corporation
  • Merck & Co.

What the Report Offers

  • Market definition for the global NDDS market along with identification of key drivers and restraints for the market.
  • Market analysis for the NDDS market, with region-specific assessments and competition analysis on a global and regional scale.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their share of markets.
  • Identification and analysis of the macro and micro factors that affect the NDDS market on both global and regional scale.
  • A comprehensive list of the key market players along with the analysis of their current strategic interests and key financial information.
RELATED REPORTS

Confused about which report to get?

Download a full report to understand our capabilities
Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license
Our Clients Include View All

Looking to Customize Report?